Transcutaneous Electrical Acustimulation (TEA) for Gastroparesis
NCT: NCT05362578 · COMPLETED
Brief Summary
The device being studied, the Transcutaneous Electrical Accustimulator (TEA), will deliver weak electrical current at two specific points, one at the leg and the other at the arm at settings known to improve symptoms involving the digestive system. The study team would like to test if the device will impact the gastrointestinal (GI) symptoms and gastric motility in study participants with gastroparesis.
Frequently Asked Questions
What is Transcutaneous Electrical Acustimulation (TEA) for Gastroparesis?
Transcutaneous Electrical Acustimulation (TEA) for Gastroparesis is a clinical trial registered under NCT05362578. Current status: COMPLETED.
What is the status of NCT05362578?
The current status of NCT05362578 (Transcutaneous Electrical Acustimulation (TEA) for Gastroparesis) is: COMPLETED.
When did Transcutaneous Electrical Acustimulation (TEA) for Gastroparesis start?
Transcutaneous Electrical Acustimulation (TEA) for Gastroparesis started on 2022-09-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.